AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF

Eastern Shore Research Institute, LLC, Fairhope, Alabama, United States

University of Arizona Sarver Heart Center, Tucson, Arizona, United States

John L. McClellan Memorial Veterans Hospital, Little Rock, Arkansas, United States

BioSolutions Clinical Research Center, Imperial, California, United States

Profound Research LLC, Pasadena, California, United States

University of California, San Francisco - Heart and Vascular Center, San Francisco, California, United States

FOMAT - Comprehensive Cardiovascular Care, Santa Maria, California, United States

Blue Coast Research Center, LLC, Vista, California, United States

New Generation of Medical Research, Hialeah, Florida, United States

Cleveland Clinic Florida, Weston, Florida, United States

Methodist Medical Center of Illinois, Peoria, Illinois, United States

Louisiana Heart Center, Slidell, Louisiana, United States

Massachusetts General Hospital, Boston, Massachusetts, United States

Mayo Clinic, Rochester, Minnesota, United States

Washington University Center for Advanced Medicine, St Louis, Missouri, United States

Morristown Medical Center, Morristown, New Jersey, United States

NYU Langone Health, New York, New York, United States

Mount Sinai West, New York, New York, United States

The Lindner Center for Research & Education at The Christ Hospital, Cincinnati, Ohio, United States

Oregon Health and Science University, Portland, Oregon, United States

University of Texas Southwestern Medical Center, Dallas, Dallas, Texas, United States

Center for Advanced Heart Failure, Houston, Texas, United States

DelRicht Research, Vienna, Virginia, United States

Swedish Heart & Vascular Institute, Advanced Cardiac Support Program, Seattle, Washington, United States

Froedtert Hospital - Center for Advanced Care, Milwaukee, Wisconsin, United States